Together these results suggest that antagonising both AR and ER together is insufficient to radiosensitise AR+/ER+ breast cancer cells in vitro further suggesting that while AR and ER may have overlapping functions, the receptors may not be working together to mediate radioresistance in models of breast cancer where they are co-expressed. The gene discussed is ESR1; the disease is breast carcinoma.